Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 54

Sort by

Sort Order Select

Journal Articles

Metabolic Signatures and Pathway Rewiring in TET2-Mutated Myeloid Neoplasia

Xiaorong Gu, Dongxu Jiang, Simon Schlanger, Nakisha D Williams, Divya Jyoti Singh, Daniel Vail, Jill Durkin, Yahan Zhang, Valeria Visconte, Jaroslaw P. Maciejewski, Babal Kant Jha

Blood (2023) 142 (Supplement 1): 2747.

https://doi.org/10.1182/blood-2023-189228

Published: 2023

Journal Articles

Insights into Large Granular Lymphocytic Leukemia-Associated Hemolytic Anemia: Clinical Associations, Therapeutic Responses, and Optimal Management Strategies from a Large Institutional Study

Olisaemeka Ogbue, Serhan Unlu, Danai Dima, Carlos Bravo-Perez, Nakisha D Williams, Arooj Ahmed, Sindhusha Veeraballi, Arda Durmaz, Fauzia Ullah, Carmelo Gurnari, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 5167.

https://doi.org/10.1182/blood-2023-186071

Published: 2023

Journal Articles

Compound Heterozygosity Involving Other Dead ( DDX ) and Deah ( DHX ) Box Helicases Explains Seemingly Monoallelic Somatic and Germline DDX41 Mutations

Valeria Visconte, Carlos Bravo-Perez, Arda Durmaz, Luca Guarnera, Ishani Nautiyal, Megan Reynold, Nakisha D Williams, Yasuo Kubota, Naomi Kawashima, Benjamin Kroger, Stephen S. Chung, David S. Bosler, Carmelo Gurnari, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 947.

https://doi.org/10.1182/blood-2023-187195

Published: 2023

Journal Articles

Molecular Landscape of c-CBL Mutation in Adults' Myeloid Malignancies

Luca Guarnera, Carmelo Gurnari, Carlos Bravo-Perez, Arda Durmaz, Nakisha D Williams, Hussein Awada, Naomi Kawashima, Arooj Ahmed, Serhan Unlu, Christopher Haddad, Aashray Mandala, Yasuo Kubota, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2023) 142 (Supplement 1): 4336.

https://doi.org/10.1182/blood-2023-184962

Published: 2023

Journal Articles

Biallelic Landscape of DNMT3A Mutant Myeloid Neoplasia

Naomi Kawashima, Yasuo Kubota, Carmelo Gurnari, Carlos Bravo-Perez, Luca Guarnera, Nakisha D Williams, Arda Durmaz, Megan Reynold, Arooj Ahmed, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2023) 142 (Supplement 1): 1469.

https://doi.org/10.1182/blood-2023-181793

Published: 2023

Journal Articles

Bone Marrow Failure and Inborn Errors of Immunity: An Immunogenomic Crossroad

Carlos Bravo-Perez, Carmelo Gurnari, Luca Guarnera, Naomi Kawashima, Serhan Unlu, Aashray Mandala, Nakisha D Williams, Arooj Ahmed, Yasuo Kubota, Arda Durmaz, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 707.

https://doi.org/10.1182/blood-2023-183000

Published: 2023

Journal Articles

Unveiling the Spectrum of Inborn Errors of Immunity: Lessons from T-Cell LGL Clonal Expansions

Carlos Bravo-Perez, Carmelo Gurnari, Luca Guarnera, Naomi Kawashima, Serhan Unlu, Aashray Mandala, Mark Orland, Olisaemeka Ogbue, Nakisha D Williams, Arooj Ahmed, Yasuo Kubota, Arda Durmaz, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 154.

https://doi.org/10.1182/blood-2023-182344

Published: 2023

Journal Articles

Association Vs Causation: Epidemiologic Clues As to the Autoimmune Pathogenesis of MDS

Nakisha D Williams, Arda Durmaz, Carlos Bravo-Perez, Yasuo Kubota, Megan Reynold, Michaela Witt, Luca Guarnera, Morgan Ferrel, Aashray Mandala, Naomi Kawashima, Carmelo Gurnari, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 4066.

https://doi.org/10.1182/blood-2023-181916

Published: 2023

Journal Articles

Differential Isoforms Signature of Splicing Factor Mutant Myeloid Neoplasia

Arda Durmaz, Carmelo Gurnari, Carlos Bravo-Perez, Luca Guarnera, Yasuo Kubota, Naomi Kawashima, Ishani Nautiyal, Sean Yetter, Nakisha D Williams, Serhan Unlu, Sindhusha Veeraballi, Arooj Ahmed, Chao-Yie Yang, John Barnard, Jacob Scott, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2023) 142 (Supplement 1): 5701.

https://doi.org/10.1182/blood-2023-184752

Published: 2023

Journal Articles

The Impact of KIR-HLA Interplay in T-LGL Leukemia

Aashray Mandala, Carlos Bravo-Perez, Nakisha D Williams, Christopher Haddad, Luca Guarnera, Simona Pagliuca, Serhan Unlu, Yasuo Kubota, Naomi Kawashima, Carmelo Gurnari, Valeria Visconte, Arda Durmaz, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 1637.

https://doi.org/10.1182/blood-2023-189268

Published: 2023

Journal Articles

Reverse Engineering of Antigenic Peptides in LGL to Decipher Disease Triggers

Arda Durmaz, Carmelo Gurnari, Simona Pagliuca, Colin Hercus, Carlos Bravo-Perez, Luca Guarnera, Nakisha D Williams, Danai Dima, Ishani Nautiyal, Yasuo Kubota, Naomi Kawashima, Jacob Scott, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 246.

https://doi.org/10.1182/blood-2023-190381

Published: 2023

Journal Articles

LGL in MGUS or MGUS in LGL? Lessons of Nature and Their Clinical Implications

Carlos Bravo-Perez, Carmelo Gurnari, Naomi Kawashima, Danai Dima, Olisaemeka Ogbue, Luca Guarnera, Yasuo Kubota, Nakisha D Williams, Arooj Ahmed, Fauzia Ullah, Arda Durmaz, Megan Nakashima, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 4769.

https://doi.org/10.1182/blood-2023-181975

Published: 2023

Journal Articles

Maladaptive Somatic Rescue in FLT3 Mutations of Suspected Germline Nature

Arooj Ahmed, Luca Guarnera, Jaymeson Gordon, Carlos Bravo-Perez, Arda Durmaz, Yasuo Kubota, Naomi Kawashima, Mark Orland, Nakisha D Williams, Christopher Haddad, Serhan Unlu, Sean Yetter, Sindhusha Veeraballi, Aashray Mandala, Carmelo Gurnari, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 5666.

https://doi.org/10.1182/blood-2023-190837

Published: 2023

Journal Articles

Genomic Analyses Unveil the Pathogenesis and Inform on Therapeutic Targeting in KMT2A -PTD AML

Yasuo Kubota, Megan Reynold, Nakisha D Williams, Naomi Kawashima, Carlos Bravo-Perez, Luca Guarnera, Christopher Haddad, Aashray Mandala, Carmelo Gurnari, Arda Durmaz, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 5696.

https://doi.org/10.1182/blood-2023-178875

Published: 2023

Journal Articles

Aspirin and antiplatelet treatments in cancer

Derrick L. Tao, Samuel Tassi Yunga, Craig D. Williams, Owen J. T. McCarty

Blood (2021) 137 (23): 3201–3211.

https://doi.org/10.1182/blood.2019003977

Published: 2021

Journal Articles

A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility

Erin C. Peckham-Gregory, Rikhia Chakraborty, Michael E. Scheurer, John W. Belmont, Harshal Abhyankar, Amel G. Sengal, Brooks P. Scull, Olive Eckstein, Daniel J. Zinn, Louisa Mayer, Albert Shih, Miriam Merad, D. Williams Parsons, Kenneth L. McClain, Philip J. Lupo, Carl E. Allen

Blood (2017) 130 (20): 2229–2232.

https://doi.org/10.1182/blood-2017-08-800565

Published: 2017

Includes: Supplemental data

Journal Articles

Lenalidomide Is a Highly Effective Maintenance Therapy in Myeloma Patients of All Ages; Results of the Phase III Myeloma XI Study

Blood (2016) 128 (22): 1143.

https://doi.org/10.1182/blood.V128.22.1143.1143

Published: 2016

Journal Articles

Primary IMiD Refractory Myeloma; Results from 3894 Patients Treated in the Phase III Myeloma XI Study

Blood (2016) 128 (22): 1144.

https://doi.org/10.1182/blood.V128.22.1144.1144

Published: 2016

Journal Articles

A Phase I Dose-Escalation Study of the Class 1 Selective Histone Deacetylase Inhibitor CHR-3996 in Combination with Tosedostat for Patients with Relapsed, Refractory Multiple Myeloma: Results of the Muk Three Trial

Rakesh Popat, Sarah R Brown, Avie-Lee Tillotson, Fiona Collinson, Louise M Flanagan, Cathy D Williams, Kwee L Yong, Gordon Cook, MD PhD, Matthew W Jenner, MD, Martin Kaiser, Jim Cavet, FRCPath, Dima El-Sharkawi, MD, Chin-Hin Ng, MD MRCP, FRCPATH, Eric Low, Gareth J Morgan, MD PhD, Faith E Davies, MD

Blood (2016) 128 (22): 3321.

https://doi.org/10.1182/blood.V128.22.3321.3321

Published: 2016

Journal Articles

Response Adapted Induction Treatment Improves Outcomes for Myeloma Patients; Results of the Phase III Myeloma XI Study

Blood (2016) 128 (22): 244.

https://doi.org/10.1182/blood.V128.22.244.244

Published: 2016

NARROW

Metabolic Signatures and Pathway Rewiring in TET2-Mutated Myeloid Neoplasia

Insights into Large Granular Lymphocytic Leukemia-Associated Hemolytic Anemia: Clinical Associations, Therapeutic Responses, and Optimal Management Strategies from a Large Institutional Study

Compound Heterozygosity Involving Other Dead ( DDX ) and Deah ( DHX ) Box Helicases Explains Seemingly Monoallelic Somatic and Germline DDX41 Mutations

Molecular Landscape of c-CBL Mutation in Adults' Myeloid Malignancies

Biallelic Landscape of DNMT3A Mutant Myeloid Neoplasia

Bone Marrow Failure and Inborn Errors of Immunity: An Immunogenomic Crossroad

Unveiling the Spectrum of Inborn Errors of Immunity: Lessons from T-Cell LGL Clonal Expansions

Association Vs Causation: Epidemiologic Clues As to the Autoimmune Pathogenesis of MDS

Differential Isoforms Signature of Splicing Factor Mutant Myeloid Neoplasia

The Impact of KIR-HLA Interplay in T-LGL Leukemia

Reverse Engineering of Antigenic Peptides in LGL to Decipher Disease Triggers

LGL in MGUS or MGUS in LGL? Lessons of Nature and Their Clinical Implications

Maladaptive Somatic Rescue in FLT3 Mutations of Suspected Germline Nature

Genomic Analyses Unveil the Pathogenesis and Inform on Therapeutic Targeting in KMT2A -PTD AML

Aspirin and antiplatelet treatments in cancer

A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility

Lenalidomide Is a Highly Effective Maintenance Therapy in Myeloma Patients of All Ages; Results of the Phase III Myeloma XI Study

Primary IMiD Refractory Myeloma; Results from 3894 Patients Treated in the Phase III Myeloma XI Study

A Phase I Dose-Escalation Study of the Class 1 Selective Histone Deacetylase Inhibitor CHR-3996 in Combination with Tosedostat for Patients with Relapsed, Refractory Multiple Myeloma: Results of the Muk Three Trial

Response Adapted Induction Treatment Improves Outcomes for Myeloma Patients; Results of the Phase III Myeloma XI Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only